Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Tumor Skin · Metastatic Melanoma · Melanoma · Lung Cancer · Metastatic Lung Cancer · Non Small Cell Lung Cancer · Metastatic Non Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The Angeles Clinic and Research Institute (Melanoma), Los Angeles, California, United States

    Contact: Study coordinator (Saba Mukarram) · SMukarram@theangelesclinic.org
    Contact: Principal Investigator (Omid Hamid, MD)
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles, California, United States

    Contact: Study coordinator (Sandy Tran) · sandy.tran@med.usc.edu · 323-865-3935
    Contact: Principal Investigator (Gino In, MD)
  • Stanford Cancer Institute (Melanoma/NSCLC), Stanford, California, United States

    Contact: Study coordinator (Samantha Lam) · samalam@stanford.edu · 650-736-3054
    Contact: Principal Investigator (Allison Betof, MD)
  • Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando, Florida, United States

    Contact: Study coordinator (Karla Ferrer) · karla.ferrer@orlandohealth.com · 321-841-6764
    Contact: Principal Investigator (Tirrell T. Johnson, MD)
  • James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville, Kentucky, United States

    Contact: Study coordinator (Melissa B. Hall) · Mmbaro01@louisville.edu
    Contact: Principal Investigator (Jason Chesney, MD, PhD)
  • Memorial Sloan Kettering (Melanoma/NSCLC), New York, New York, United States

    Melanoma · 6464979067
    NSCLC · 6464979163
    Contact: Principal Investigator (Alexander Shoushtari, MD)
  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Miranda Bean) · Miranda.bean@osumc.edu · 6142934254
    Contact: Principal Investigator (Timothy Burns, MD)
  • Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Lindsay Brown) · lindsey.brown@ahn.org
    Contact: Principal Investigator (Thomas Curley, MD)
  • M.D. Anderson Cancer Center (Melanoma/NSCLC), Houston, Texas, United States

    Contact: Study coordinator (Steffy Jose) · SJose3@mdanderson.org
    Contact: Principal Investigator (Rodabe Amaria, MD)